Goodwill and Other Intangible Assets

3 Months Ended

Mar. 31, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill:

The following table sets forth the change in the carrying amount of goodwill for each reportable segment and for the Company as of and for the period ended March 31, 2018:



	Industrial		Aerospace		Total Company
January 1, 2018	$	659,437	$	30,786	$	690,223
Foreign currency translation	15,071		—		15,071
March 31, 2018	$	674,508	$	30,786	$	705,294

Other Intangible Assets:

Other intangible assets consisted of:



		March 31, 2018						December 31, 2017
	Range of Life -Years	Gross Amount			Accumulated Amortization			Gross Amount			Accumulated Amortization
Amortized intangible assets:
Revenue sharing programs (RSPs)	Up to 30	$	293,700		$	(111,717	)	$	293,700		$	(108,075	)
Component repair programs (CRPs)	Up to 30	111,839			(17,783		)	111,839			(16,508		)
Customer lists/relationships	10-16	215,966			(68,625		)	215,966			(65,385		)
Patents and technology	4-10	87,052			(50,838		)	87,052			(48,083		)
Trademarks/trade names	10-30	11,950			(10,446		)	11,950			(10,349		)
Other	Up to 15	20,551			(16,519		)	20,551			(16,414		)
		741,058			(275,928		)	741,058			(264,814		)
Unamortized intangible assets:
Trade names		42,770			—			42,770			—
Foreign currency translation		(6,091		)	—			(11,972		)	—
Other intangible assets		$	777,737		$	(275,928	)	$	771,856		$	(264,814	)

Estimated amortization of intangible assets for future periods is as follows: 2018 - $41,000; 2019 - $41,000; 2020 - $37,000; 2021 - $37,000 and 2022 - $37,000.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details